From April 16 to 18, local time in New York, INTERPHEX 2024 opened at the Javits Center. As North America’s largest and most prestigious pharmaceutical industry exhibition, it drew top pharmaceutical equipment manufacturers from around the world, showcasing the latest in industry technology and innovation.

As a professional manufacturer in the field of pharmaceutical equipment, Tailin showcased our new product, the Hot Cells For Radiopharmaceutical Production, for the first time at an international exhibition. This product provides a systematic solution that meets the highest industry standards for the production of radiopharmaceuticals, leading the way in safe and efficient nuclear medicine production. Its unique design, high efficiency, and excellent safety features received widespread attention from attendees.

After years of deep cultivation in the industry, Tailin has continuously expanded our product line to meet niche market demands, resulting in a well-rounded product matrix and solutions. The equipment displayed at this exhibition, including the Sterility Test Isolator, Scan Counter Workstation, Filter Integrity Tester,  and Membrane Dispenser, showcased Tailin’s profound technical expertise and innovative capabilities in the field of pharmaceutical equipment, highlighting the elegance and strength of Chinese pharmaceutical enterprises.

At the exhibition, the overseas team staff warmly received every visitor, providing detailed introductions to the features and advantages of the products, and engaged in in-depth discussions with attendees about the development trends and market demands of the pharmaceutical industry. With its professional technology, outstanding products, and high-quality service, Tailin garnered widespread praise and recognition from the participants.

This conference was not only a platform for showcasing technology but also a place for the exchange of ideas on industry trends and future opportunities. As a member of the medical and healthcare sector, Tailin will continue to uphold our responsibility to advance the health industry. Through relentless technological innovation and service optimization, we are committed to contributing to the health and well-being of humanity.

In the future, the company will continue to advance our overseas strategy, constantly enhancing our corporate strength, accelerating our pace of innovation and upgrading, and striving to capture the high ground in development. We are committed to becoming the most trusted partner of global biopharmaceutical enterprises, helping Chinese brand companies reach a larger stage on the world platform.